-
EP4129994
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4129994
| EP4129994 - NOVEL PYRIMIDINE DERIVATIVE, AND COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND CANCER, COMPRISING SAME [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 06.01.2023 Database last updated on 13.11.2024 | |
| Former | The international publication has been made Status updated on 02.10.2021 | Most recent event Tooltip | 30.09.2024 | The date on which the examining division becomes responsible, has been established | 30.09.2024 | Amendment by applicant | Applicant(s) | For all designated states Whan In Pharmaceutical Co., Ltd. 11, Beobwon-ro 6-gil Songpa-gu, Seoul 05855 / KR | For all designated states Korea Research Institute of Chemical Technology 141, Gajeong-ro Yuseong-gu Daejeon 34114 / KR | [2023/06] | Inventor(s) | 01 /
LEE, Ge Hyeong 1F, 141, Gajeong-ro, Yuseong-gu Daejeon 34114 / KR | 02 /
SEO, Jee Yeon 1F, 107, Gwanggyo-ro, Yeongtong-gu Suwon-si, Gyeonggi-do 16229 / KR | 03 /
YU, Jeong Heon 1F, 107, Gwanggyo-ro, Yeongtong-gu Suwon-si, Gyeonggi-do 16229 / KR | 04 /
YE, In Hae 1F, 107, Gwanggyo-ro, Yeongtong-gu Suwon-si, Gyeonggi-do 16229 / KR | 05 /
SHIN, Ho Chul 1F, 107, Gwanggyo-ro, Yeongtong-gu Suwon-si, Gyeonggi-do 16229 / KR | 06 /
SUH, Jee Hee 1F, 141, Gajeong-ro, Yuseong-gu Daejeon 34114 / KR | 07 /
KIM, Seong Hwan 1F, 141, Gajeong-ro, Yuseong-gu Daejeon 34114 / KR | 08 /
SONG, Jin Sook 1F, 141, Gajeong-ro, Yuseong-gu Daejeon 34114 / KR | 09 /
SIM, Seong Hyeon 1F, 141, Gajeong-ro, Yuseong-gu Daejeon 34114 / KR | 10 /
CHAE, Chong Hak 1F, 141, Gajeong-ro, Yuseong-gu Daejeon 34114 / KR | 11 /
KANG, Hee Yeon 1F, 141 Gajeong-ro, Yuseong-gu Daejeon 34114 / KR | 12 /
LEE, Ji Hun 1F, 141, Gajeong-ro, Yuseong-gu Daejeon 34114 / KR | 13 /
HWANG, Keon Ha 1F, 141, Gajeong-ro, Yuseong-gu Daejeon 34114 / KR | [2023/06] | Representative(s) | Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | [N/P] |
| Former [2023/06] | Gerauer, Marc Philippé Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | Application number, filing date | 21775221.1 | 12.03.2021 | [2023/06] | WO2021KR03120 | Priority number, date | KR20200035257 | 23.03.2020 Original published format: KR 20200035257 | KR20210018223 | 09.02.2021 Original published format: KR 20210018223 | [2023/06] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021194144 | Date: | 30.09.2021 | Language: | KO | [2021/39] | Type: | A1 Application with search report | No.: | EP4129994 | Date: | 08.02.2023 | Language: | EN | [2023/06] | Search report(s) | International search report - published on: | KR | 30.09.2021 | (Supplementary) European search report - dispatched on: | EP | 26.03.2024 | Classification | IPC: | C07D401/14, C07D405/14, C07D403/04, A61K31/506, A61K31/5377, A61P25/28 | [2024/17] | CPC: |
C07D401/14 (EP,US);
A61P25/28 (EP);
C07D403/04 (EP,US);
C07D405/14 (EP,US);
C07D413/14 (EP,US);
C07D471/04 (EP,US);
C07D487/04 (EP,US);
C07D491/08 (EP);
C07D491/107 (EP,US);
C07D491/18 (US)
(-)
|
| Former IPC [2023/06] | C07D403/04, A61K31/506, A61K31/5377, A61P25/28, C07D401/14, C07D405/14 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/06] | Title | German: | NEUARTIGES PYRIMIDINDERIVAT UND ZUSAMMENSETZUNG ZUR PRÄVENTION ODER BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN UND KREBS DAMIT | [2023/06] | English: | NOVEL PYRIMIDINE DERIVATIVE, AND COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND CANCER, COMPRISING SAME | [2023/06] | French: | NOUVEAU DÉRIVÉ DE PYRIMIDINE, ET COMPOSITION POUR LA PRÉVENTION OU LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES ET DU CANCER, COMPRENANT CELUI-CI | [2023/06] | Entry into regional phase | 14.10.2022 | Translation filed | 14.10.2022 | National basic fee paid | 14.10.2022 | Search fee paid | 14.10.2022 | Designation fee(s) paid | 14.10.2022 | Examination fee paid | Examination procedure | 14.10.2022 | Examination requested [2023/06] | 30.09.2024 | Amendment by applicant (claims and/or description) | 30.09.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 17.02.2023 | Renewal fee patent year 03 | 11.03.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]CN103864770 (JIANGSU SIMCERE PHARMACEUTICAL); | International search | [A]WO0129009 (CELLTECH CHIROSCIENCE LTD [GB], et al); | [X]US2004235875 (FRALEY MARK E [US], et al); | [X]KR20080059423 (ASTRAZENECA AB [SE]); | [X]KR101580482B ; | [A]KR20200020622 (DAEGU GYEONGBUK MEDICAL INNOVATION FOUND [KR], et al) | by applicant | KR101208198B | KR101566091B | KR20190018676 | KR102025451B |